Upon binding to its ligand, PD-L1—expressed on both antigen-presenting cells and tumor cells—PD-1 signaling suppresses T cell receptor (TCR)-mediated activation, leading to reduced cytokine production, the inhibition of T cell proliferation, and impaired cytotoxic function [2]. The gene discussed is CD274; the disease is neoplasm.